Franco Fabbiocchi

TL;DR: Intravenous and oral N-acetylcysteine may prevent contrast-medium–induced nephropathy with a dose-dependent effect in patients treated with primary angioplasty and may improve hospital outcome.

TL;DR: In patients with chronic renal failure who are undergoing percutaneous coronary interventions, periprocedural hemofiltration given in an ICU setting appears to be effective in preventing the deterioration of renal function due to contrast-agent-induced nephropathy and is associated with improved in-hospital and long-term outcomes.

TL;DR: This randomised controlled trial sought to establish whether or not a novel OCT-based stent sizing strategy would result in a minimum stent area similar to or better than that achieved with IVUS guidance and better than those achieved with angiography guidance alone.

TL;DR: Evidence-based recommendations to guide best procedural strategies during primary PCI are still lacking and the relation between the volume of contrast administered during interventional procedures and the risk for CIN remains unknown.

TL;DR: The simultaneous presence of four high-risk OCT plaque features was found to be associated with a higher risk of major coronary events.